Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.

Abstract

The choice of either induction or postremission therapy for adults with acute myeloid leukemia is still largely based on the "one size fits all" principle. Moreover, pretreatment prognostic parameters, especially chromosome and gene abnormalities, may fail in predicting individual patient outcome. Measurement of minimal residual disease (MRD) is nowadays… (More)
DOI: 10.1182/blood-2011-08-363291

Topics

5 Figures and Tables

Cite this paper

@article{Buccisano2012PrognosticAT, title={Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia.}, author={Francesco Buccisano and Luca Maurillo and Maria Ilaria del Principe and Giovanni del Poeta and Giuseppe Sconocchia and Francesco Lo-Coco and William Arcese and Sergio Amadori and Adriano Venditti}, journal={Blood}, year={2012}, volume={119 2}, pages={332-41} }